Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Long-Term Clinical Outcomes of Allogeneic Stem Cell Transplantation in Multiple Myeloma

Elena Zamagni, Giuseppe Bandini, Annalisa Pezzi, PhD, Paola Tacchetti, Ilaria Rizzello, Lucia Pantani, Mario Arpinati, MD PhD, Beatrice A Zannetti, MD, Serena Rocchi, Mariarosaria Sessa, Annamaria Brioli, Katia Mancuso, Carolina Terragna, PhD, Nicoletta Testoni, Francesca Bonifazi, Michele Cavo, MD

Blood (2015) 126 (23): 1968.

https://doi.org/10.1182/blood.V126.23.1968.1968

Published: 2015

Journal Articles

Donor Natural Killer (NK) Alloreactivity Predicts Long-Term Relapse-Free Survival in Acute Myeloid Leukemia Patients Undergoing Immunotherapy with NK Cells

Blood (2014) 124 (21): 624.

https://doi.org/10.1182/blood.V124.21.624.624

Published: 2014

Journal Articles

Prevention of Chronic GvHD after HLA-Identical Sibling Peripheral Hematopietic Stem Cell Transplantation with or without Anti-Lymphocyte Globulin (ATG). Results from a Prospective, Multicenter Randomized Phase III Trial (ATGfamilystudy)

Blood (2014) 124 (21): 37.

https://doi.org/10.1182/blood.V124.21.37.37

Published: 2014

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Evolution and Outcomes over More Than Two Decades within EBMT Centers

Blood (2014) 124 (21): 2554.

https://doi.org/10.1182/blood.V124.21.2554.2554

Published: 2014

Journal Articles

Allogeneic Bone Marrow Transplantation From Unrelated Donors in Multiple Myeloma: A Study from the Italian Bone Marrow Transplantation Donor Registry

Blood (2011) 118 (21): 2009.

https://doi.org/10.1182/blood.V118.21.2009.2009

Published: 2011

Journal Articles

Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients

Antonio Curti, Loredana Ruggeri, Alessandra D'Addio, Andrea Bontadini, Elisa Dan, Maria Rosa Motta, Sara Trabanelli, Valeria Giudice, Elena Urbani, Giovanni Martinelli, Stefania Paolini, Fiorenza Fruet, Alessandro Isidori, Sarah Parisi, Giuseppe Bandini, Michele Baccarani, Andrea Velardi, Roberto M. Lemoli

Blood (2011) 118 (12): 3273–3279.

https://doi.org/10.1182/blood-2011-01-329508

Published: 2011

Includes: Supplemental data

Journal Articles

Long Term Study of the Impact of Quantitative Molecular Monitoring of Bcr-Abl Transcripts on the Risk of Relapse of CML After Allogeneic HSCT.

Mario Arpinati, MD, PhD, Marilina Amabile, maria Teresa Bochicchio, Angela Poerio, Giuseppe Bandini, Francesca Bonifazi, MD, Marta Stanzani, MD, PhD, Fausto Castagnetti, Gianantonio Rosti, Giovanni Martinelli, Michele Baccarani, MD

Blood (2010) 116 (21): 1287.

https://doi.org/10.1182/blood.V116.21.1287.1287

Published: 2010

Journal Articles

Adoptive Immunotherapy with Haploidentical Kir Ligand-Mismatched Natural Killer Cells In Elderly High Risk Acute Myeloid Leukemia Patients: Biological and Clinical Results of A Pilot Study

Antonio Curti, PhD, Loredana Ruggeri, PhD, Alessandra D'Addio, Andrea Bontadini, PhD, Valeria Giudice, PhD, Elisa Dan, PhD, Maria Rosa Motta, PhD, Simonetta Rizzi, Sara Trabanelli, PhD, Elena Urbani, PhD, Giovanni Martinelli, PhD, Stefania Paolini, PhD, Fiorenza Fruet, PhD, Alessandro Isidori, Beatrice Casadei, PhD, Giuseppe Bandini, PhD, Michele Baccarani, PhD, Andrea Velardi, PhD, Roberto M. Lemoli

Blood (2010) 116 (21): 4287.

https://doi.org/10.1182/blood.V116.21.4287.4287

Published: 2010

Journal Articles

Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation

Roberto Crocchiolo, Elisabetta Zino, Luca Vago, Rosi Oneto, Barbara Bruno, Simona Pollichieni, Nicoletta Sacchi, Maria Pia Sormani, Jessica Marcon, Teresa Lamparelli, Renato Fanin, Lucia Garbarino, Valeria Miotti, Giuseppe Bandini, Alberto Bosi, Fabio Ciceri, Andrea Bacigalupo, Katharina Fleischhauer, for the Gruppo Italiano Trapianto di Midollo Osseo, Cellule Staminale Ematopoietiche (CSE) e Terapia Cellulare, and the Italian Bone Marrow Donor Registry

Blood (2009) 114 (7): 1437–1444.

https://doi.org/10.1182/blood-2009-01-200378

Published: 2009

Journal Articles

NON-Permissive HLA-DPB1 T CELL Epitope Disparities Correlate with Engraftment and Survival after Unrelated Stem Cell Transplantation

Roberto Crocchiolo, M.D., Elisabetta Zino, M.D., Nicoletta Sacchi, Ph.D., Jessica Marcon, M.D., Simona Pollichieni, Ph.D., Rosi Oneto, Ph.D., Giuseppe Bandini, M.D., Andrea Bacigalupo, MD, Fabio Ciceri, M.D., Katharina Fleischhauer, M.D.

Blood (2008) 112 (11): 562.

https://doi.org/10.1182/blood.V112.11.562.562

Published: 2008

Journal Articles

Long-Term Outcome of Therapy-Related Myelodysplastic Syndromes and Acute Myeloid Leukemias Arising in Patients Treated for Lymphoma or Solid Tumors.

Raffaella Milani, Salvatore Palmieri, Manuela Zanni, Filiberto Pollio, Anna Dodero, Francesco Spina, Adele Testi, Corrado Tarella, Massimo Bernardi, Andrea Gallamini, Giuseppe Bandini, Fabio Benedetti, Felicetto Ferrara, Paolo Corradini

Blood (2007) 110 (11): 2464.

https://doi.org/10.1182/blood.V110.11.2464.2464

Published: 2007

Journal Articles

Effect of HLA-Matching on Outcome of Hematopoietic Stem Cell Transplantation from Unrelated Donors: A IBMDR-GITMO Study.

Roberto Crocchiolo, MD, Fabio Ciceri, MD, Rosa Oneto, MD, Barbara Bruno, MD, Simona Pollichieni, MD, Nicoletta Sacchi, MD, Maria Pia Sormani, MD, Renato Fanin, MD, Giuseppe Bandini, MD, Alberto Bosi, MD, Alessandro Rambaldi, MD, Paolo Emilio Alessandrino, MD, Michele Falda, MD, Andrea Bacigalupo, MD

Blood (2007) 110 (11): 3052.

https://doi.org/10.1182/blood.V110.11.3052.3052

Published: 2007

Journal Articles

Allogeneic and syngeneic hematopoietic cell transplantation in patients with amyloid light-chain amyloidosis: a report from the European Group for Blood and Marrow Transplantation

Blood (2006) 107 (6): 2578–2584.

https://doi.org/10.1182/blood-2005-06-2462

Published: 2006

Journal Articles

Imatinib Therapy for Chronic Myeloid Leukemia Patients Who Relapse after Allogeneic Stem Cell Transplantation: A Molecular Analysis.

Blood (2004) 104 (11): 4655.

https://doi.org/10.1182/blood.V104.11.4655.4655

Published: 2004

Journal Articles

Effect of Age and Previous Autologous Transplant on Treatment-Related Mortality and GVHD in 140 Patients Treated with Reduce-Intensity Conditioning and Allograft for Advanced Hematological Malignancies.

Paolo Corradini, M.D., Francesco Zallio, M.D., Jacopo Mariotti, M.D., Pinuccia Valagussa, M.D., Anna Dodero, M.D., Marco Bregni, M.D., Fabio Ciceri, M.D., Andrea Bacigalupo, M.D., Moira Lucesole, M.D., Francesca Patriarca, M.D., Andrea Rambaldi, M.D., Rosanna Scimè, M.D., Giuseppe Bandini, M.D., Alessandro M. Gianni, M.D., Corrado Tarella, M.D., Attilio Olivieri, M.D.

Blood (2004) 104 (11): 5138.

https://doi.org/10.1182/blood.V104.11.5138.5138

Published: 2004

Journal Articles

Pretransplant Recipient Blood CD14+ preDC Levels Correlate with Increased Acute GVHD after Allogeneic PBSC Transplantation.

Mario Arpinati, MD, Panagiota Giannoullia, MD, Gabriella Chirumbolo, BS, Giulia Perrone, MD, Francesca Bonifazi, MD, Yogen Sanuthararajah, MD, Francesca Palandri, MD, Maria Benedetta Giannini, MD, Giuseppe Bandini, MD, Valeria Martelli, Sara Sanchini, BS, Michele Baccarani, MD, Damiano Rondelli, MD

Blood (2004) 104 (11): 1226.

https://doi.org/10.1182/blood.V104.11.1226.1226

Published: 2004

Journal Articles

Identical-Twin Transplants for B-Cell Chronic Lymphocytic Leukemia (B-CLL).

Steven Pavletic, MD, Guimei Zhou, MD, Kathleen Sobocinski, MS, Kristine Doney, MD, John DiPersio, MD, Walter Feremans, MD, Letizia Foroni, MD, H. Grant Prentice, MBBS, Charles LeMaistre, MD, Giuseppe Bandini, MD, Augustin Ferrant, MD, Niels Jacobsen, MD, Issa Khouri, MD, Robert Peter Gale, MD, Sergio Giralt, MD, Emilio Montserrat, MD, John Chan, MD, Christopher Bredeson, MD

Blood (2004) 104 (11): 3330.

https://doi.org/10.1182/blood.V104.11.3330.3330

Published: 2004

Journal Articles

A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation

Blood (2004) 103 (4): 1417–1424.

https://doi.org/10.1182/blood-2003-04-1279

Published: 2004

Journal Articles

Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow

Norbert C. Gorin, Myriam Labopin, Vanderson Rocha, William Arcese, Meral Beksac, Eliane Gluckman, Olle Ringden, Tapani Ruutu, Josy Reiffers, Giuseppe Bandini, Michele Falda, Panagiotis Zikos, Roelf Willemze, Francesco Frassoni, for the Acute Leukemia Working Party (ALWP) of the European Cooperative Group for Blood and Marrow Transplantation (EBMT)

Blood (2003) 102 (8): 3043–3051.

https://doi.org/10.1182/blood-2003-03-0665

Published: 2003

Journal Articles

Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia

Alois Gratwohl, Ronald Brand, Jane Apperley, Anja v. Biezen, Giuseppe Bandini, Agnes Devergie, Anton Schattenberg, Francesco Frassoni, Cesare Guglielmi, Simona Iacobelli, Mauricette Michallet, Hans-Jochen Kolb, Tapani Ruutu, Dietger Niederwieser

Blood (2002) 100 (12): 3877–3886.

https://doi.org/10.1182/blood.V100.12.3877

Published: 2002

NARROW

Long-Term Clinical Outcomes of Allogeneic Stem Cell Transplantation in Multiple Myeloma

Donor Natural Killer (NK) Alloreactivity Predicts Long-Term Relapse-Free Survival in Acute Myeloid Leukemia Patients Undergoing Immunotherapy with NK Cells

Prevention of Chronic GvHD after HLA-Identical Sibling Peripheral Hematopietic Stem Cell Transplantation with or without Anti-Lymphocyte Globulin (ATG). Results from a Prospective, Multicenter Randomized Phase III Trial (ATGfamilystudy)

Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Evolution and Outcomes over More Than Two Decades within EBMT Centers

Allogeneic Bone Marrow Transplantation From Unrelated Donors in Multiple Myeloma: A Study from the Italian Bone Marrow Transplantation Donor Registry

Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients

Long Term Study of the Impact of Quantitative Molecular Monitoring of Bcr-Abl Transcripts on the Risk of Relapse of CML After Allogeneic HSCT.

Adoptive Immunotherapy with Haploidentical Kir Ligand-Mismatched Natural Killer Cells In Elderly High Risk Acute Myeloid Leukemia Patients: Biological and Clinical Results of A Pilot Study

Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation

NON-Permissive HLA-DPB1 T CELL Epitope Disparities Correlate with Engraftment and Survival after Unrelated Stem Cell Transplantation

Long-Term Outcome of Therapy-Related Myelodysplastic Syndromes and Acute Myeloid Leukemias Arising in Patients Treated for Lymphoma or Solid Tumors.

Effect of HLA-Matching on Outcome of Hematopoietic Stem Cell Transplantation from Unrelated Donors: A IBMDR-GITMO Study.

Allogeneic and syngeneic hematopoietic cell transplantation in patients with amyloid light-chain amyloidosis: a report from the European Group for Blood and Marrow Transplantation

Imatinib Therapy for Chronic Myeloid Leukemia Patients Who Relapse after Allogeneic Stem Cell Transplantation: A Molecular Analysis.

Effect of Age and Previous Autologous Transplant on Treatment-Related Mortality and GVHD in 140 Patients Treated with Reduce-Intensity Conditioning and Allograft for Advanced Hematological Malignancies.

Pretransplant Recipient Blood CD14+ preDC Levels Correlate with Increased Acute GVHD after Allogeneic PBSC Transplantation.

Identical-Twin Transplants for B-Cell Chronic Lymphocytic Leukemia (B-CLL).

A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation

Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow

Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only